Weiss Multi Strategy Advisers LLC Esperion Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$19.4 - $28.71 $242,364 - $358,674	-12,493 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$25.12 - $36.89 $38,333 - $56,294	-1,526 Reduced 10.89%	12,493 $350,000
Q4 2020 Feb 16, 2021	BUY	$24.2 - $35.76 $22,457 - $33,185	928 Added 7.09%	14,019 $364,000
Q3 2020 Nov 16, 2020	BUY	$31.18 - $52.71 $189,917 - $321,056	6,091 Added 87.01%	13,091 $487,000
Q2 2020 Aug 14, 2020	BUY	$30.04 - $51.31 $210,280 - $359,170	7,000 New	7,000 $359,000

207

128M

1.67M

930K

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $155M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.